ArticlePediatric endocrinology, diabetes, and metabolism2026
Oxidative stress and insulin resistance in Libyan Down syndrome individuals: assessment and association compared to a healthy comparison group.
Article in Pediatric endocrinology, diabetes, and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIndividuals with Down syndrome (DS) are at increased risk of metabolic disturbances, including oxidative stress (OS) and insulin resistance (IR). The relationship between OS and IR in this population remains unclear. AIM OF THE STUDY: To assess OS and IR in Libyan individuals with DS and examine the influence of adiposity and age. MATERIAL AND
methodsFifty individuals with DS (aged 5-25 years) and 58 age-, sex-, and body mass index-matched individuals (comparison group, CG) were included. Anthropometric measurements, fasting glucose, insulin, malondialdehyde (MDA), and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) were assessed. Associations between MDA, HOMA-IR, and body composition were evaluated.
resultsNo significant correlation was found between MDA and HOMA-IR (r = 0.064, p = 0.661). No significant difference in HOMA-IR was observed between the DS group and the CG (p = 0.822), although 44% of DS subjects showed elevated HOMA-IR. In contrast, MDA levels were significantly higher in the DS group compared to the CG (p < 0.001), but remained within the normal range.
conclusionsIR in DS appears to be mainly driven by adiposity rather than the syndrome itself, while OS is elevated but largely independent of IR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.